Why Tekton?
Proven outcomes across trials and teams.
At Tekton, we believe the best measure of success is real-world impact. That’s why we let the results speak for themselves. Below, you’ll find a selection of case studies that showcase how our work drives measurable outcomes for sponsors, patients, and partners.
Case Studies
Targets surpassed
Tekton exceeded enrollment targets across all 3 sites in a Type 1 Diabetes trial, with our McKinney, TX site more than doubling its goal—prompting the sponsor to spotlight our team as a model for best practices.
Rapid Enrollment, Record Results
Tekton delivered 172% average enrollment across 7 sites, for a total of >720 patients for a 2024 Global Phase 3 vaccine clinical trial.
Accelerated Enrollment
Tekton Research sites averaged just 1 day from activation to first patient visit for a phase 3 norovirus vaccine trial, with 3 of 7 sites achieving this milestone in under 24 hours.
Setting the Pace: First Patient In
Tekton Research led the way in an Alzheimer’s Disease trial by enrolling the study’s first patient, surpassing enrollment goals and contributing to protocol design.
Browse All Case Studies
Partner With Us
Join the leading sponsors and CROs who trust Tekton Research with their most important neurology, CNS, psychiatry, and general medicine clinical trials. Contact us today to discuss how our specialized expertise can help bring your next breakthrough treatment to patients in need.